Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text
.png)




Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmacology
In Vitro Assays
Cell Culture & Characterization
BPS Bioscience Inc.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Real-World Data (RWD)
Market Access
No items found.

Blog
Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery
June 16, 2026
Read blog
Discovery Chemistry
Pharmacology
Protein Sciences
SandboxAQ
.png)
Blog
Reducing risk in CRO studies: Choosing the right cell models for outsourced research
June 11, 2026
Read blog
Cell Culture & Characterization
In Vitro Assays
HBS
Toxicology
Pharmacology
PromoCell
Chemistry, Manufacturing & Controls
Raw Materials
DNA & RNA
Landmark Bio
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Ontada
In Vitro Assays
Cell Culture & Characterization
Protein Sciences
DNA & RNA
BPS Bioscience Inc.
Biomarkers
DNA & RNA
Instrumentation & Products
Diagenode
Discovery Chemistry
Protein Sciences
In Vitro Assays
Pharmacology
WuXi AppTec

Blog
AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation
April 23, 2026
Read blog
Health Economics & Outcomes Research (HEOR)
Panalgo, LLC

Blog
AI Is Expanding What's Possible in Drug Discovery. Operational Friction Still Determines How Fast It Happens.
April 17, 2026
Read blog
Pharmacology
No items found.
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Colin Oliver
Anila Dede
Erwin De Cock
Arshi Gupta
Syneos Health
HealthEconomics.com
Disease Models
Instrumentation & Products
Trent Lund
Flavia Teixeira Silva
Stoelting Co.
No items found.
Clinical Trials
Market Access
Real-World Evidence (RWE)
Renee Willmon
Self Care Catalysts, an Alira Health Company
HealthEconomics.com
Cell Culture & Characterization
Pharmacology
Johannes Waldschmidt
Andreas Thomsen
Marco Leu
abc biopply
American Physiological Society
Health Economics & Outcomes Research (HEOR)
Earlene Biggs
Gary Owens
Renee Fleming
ICON
HealthEconomics.com
Pharmacology
DNA & RNA
Peter Ansell
Marian Navratil
HTG Molecular Diagnostics, Inc.
Scientist.com
Disease Models
Instrumentation & Products
Louise Naylor
No items found.
American Physiological Society
European Council for Cardiovascular Research
Disease Models
Augusto Montezano
No items found.
American Physiological Society
European Council for Cardiovascular Research
Pharmacology
Cathie G. Miller
David Bunka
Henry Sebesta
BioIVT
Aptamer Group
KromaTiD, Inc.
Scientist.com
HealthEconomics.com
Real-World Data (RWD)
Real-World Evidence (RWE)
Raina Olexa
Mui Van Zandt
IQVIA
HealthEconomics.com
Clinical Trials
Disease Models
Cell Culture & Characterization
Disease Models

Podcast
Industry Insights with Amy Sheng on Nanobodies: An Important Tool for the Next Generation of Tumor Diagnostics and Therapeutics
September 27, 2022
Read podcast
Antibodies
Pharmacology
Disease Models
Instrumentation & Products
Disease Models
Pharmacology
Clinical Trials
Disease Models
No items found.

Podcast
#ExpertAnswers: Valeria Fumagalli and Nancy Kouassi on the Syrian golden hamster model of COVID-19
August 18, 2022
Read podcast
Disease Models
Toxicology
Antibodies
Biomarkers
Pharmacology
Real-World Evidence (RWE)
Medical Communications
Cell Culture & Characterization
Biomarkers
Pharmacology
DNA & RNA
No items found.
Clinical Trials
In Vitro Assays
Disease Models
Disease Models
Medical Communications




































